RAB001 medium dose

DRUG2 trials

Sponsors

ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd.

Conditions

Knee OsteoarthritisOsteonecrosisOsteonecrosis of the Femoral Head

Phase 1

Phase Ib Trial of Injectable RAB001 for Knee Osteoarthritis

Enrolling by invitationNCT07652372

ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd.Knee Osteoarthritis

Start: 2026-04-16End: 2027-09-30Target: 60Updated: 2026-06-17

Phase 2

A Phase II Trial of RAB001 (LLP2A-Alendronate) for Steroid-Induced Early-Stage Osteonecrosis of the Femoral Head

Active, not recruitingNCT07471880

ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd.Osteonecrosis, Osteonecrosis of the Femoral Head

Start: 2024-12-24End: 2027-02-28Updated: 2026-03-24